✦ LIBER ✦

PSY38 COST-EFFECTIVENESS OF GOLIMUMAB IN ANKYLOSING SPONDYLITIS FROM THE UK PAYER PERSPECTIVE

✍ Scribed by Muszbek, N; Punekar, Y; Buchanan, J; Prasad, M; Vioix, H; Brown, R

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PMS34 COST-EFFECTIVENESS OF GOLIMUMAB IN

✍ E Cummins; C Asseburg; M Prasad; J Buchanan; Y Punekar 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

PMS29 Cost Effectiveness of Adalimumab V

✍ A. Marcellusi; M.F. Botteman; S. Rao; M. Cifaldi; C.T. Solem; L. Gitto; P. Giann 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

Infliximab cost effective for ankylosing

📂 Article 📅 2004 🏛 Adis International Limited (now part of Wolters Kl ⚖ 139 KB

PSY37 COST-EFFECTIVENESS AND BUDGET IMPA

✍ Fernandes, RA; Takemoto, ML; Guerra, FC; Passos, RB; Pereira, ML; Morais, AD 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB

PHP65 THE IMPACT AND CHALLENGES OF INCLU

✍ DE Spackman; JD Campbell 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB

Assessment of Cost-Effectiveness Models

✍ Gokhale, S.; Mallya, U.; Mpofu, S. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB